Cargando…
Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer
The neddylation pathway has been recognized as an attractive anticancer target in several malignancies, and its selective inhibitor, MLN4924, has recently advanced to clinical development. However, the anticancer effect of this compound against prostate cancer has not been well investigated. In this...
Autores principales: | Wang, Xiaofang, Li, Lihui, Liang, Yupei, Li, Chunjie, Zhao, Hu, Ye, Dingwei, Sun, Menghong, Jeong, Lak Shin, Feng, Yan, Fu, Shen, Jia, Lijun, Guo, Xiaomao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100379/ https://www.ncbi.nlm.nih.gov/pubmed/25093192 http://dx.doi.org/10.1155/2014/974309 |
Ejemplares similares
-
Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer
por: Chen, Ping, et al.
Publicado: (2015) -
Neddylation Regulates Macrophages and Implications for Cancer Therapy
por: Jiang, Yanyu, et al.
Publicado: (2021) -
Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
por: Wang, Xiaofang, et al.
Publicado: (2016) -
Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
por: Li, Hua, et al.
Publicado: (2017) -
Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells
por: Liang, Yupei, et al.
Publicado: (2020)